Financial News

As globe gallops into vaccine trials, insurers remain unfazed

The world is racing towards a vaccine in record time, stirring public concerns about safety to the extent that nine leading developers have felt compelled to issue a pledge to uphold scientific standards and testing rigour.

Exit mobile version
Skip to toolbar